274 related articles for article (PubMed ID: 19141094)
41. ANCA vasculitis in the elderly.
Hoganson DD; From AM; Michet CJ
J Clin Rheumatol; 2008 Apr; 14(2):78-81. PubMed ID: 18391675
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.
Gottenberg JE; Mahr A; Pagnoux C; Cohen P; Mouthon L; Guillevin L;
Presse Med; 2007 May; 36(5 Pt 1):771-8. PubMed ID: 17416480
[TBL] [Abstract][Full Text] [Related]
43. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
[TBL] [Abstract][Full Text] [Related]
44. [Severe chronic headache with depression induced by pachymeningitis in Wegener's granulomatosis].
von Bierbrauer A; Pelzer C; Fischer V
Dtsch Med Wochenschr; 2008 Feb; 133(5):185-8. PubMed ID: 18213550
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of Wegener's granulomatosis in northern Norway.
Koldingsnes W; Nossent H
Arthritis Rheum; 2000 Nov; 43(11):2481-7. PubMed ID: 11083271
[TBL] [Abstract][Full Text] [Related]
46. Tarsal-conjunctival disease associated with Wegener's granulomatosis.
Robinson MR; Lee SS; Sneller MC; Lerner R; Langford CA; Talar-Williams C; Cox TA; Chan CC; Smith JA
Ophthalmology; 2003 Sep; 110(9):1770-80. PubMed ID: 13129876
[TBL] [Abstract][Full Text] [Related]
47. Predictors of survival and organ damage in Wegener's granulomatosis.
Koldingsnes W; Nossent H
Rheumatology (Oxford); 2002 May; 41(5):572-81. PubMed ID: 12011383
[TBL] [Abstract][Full Text] [Related]
48. Wegener's granulomatosis strictly and persistently localized to one organ is rare: assessment of 16 patients from the French Vasculitis Study Group database.
Pagnoux C; Stubbe M; Lifermann F; Decaux O; Pavic M; Bérezné A; Delacroix-Szmania I; Méaux-Ruault N; Bienvenu B; Cabane J; Guillevin L;
J Rheumatol; 2011 Mar; 38(3):475-8. PubMed ID: 21123319
[TBL] [Abstract][Full Text] [Related]
49. Vasculitides associated with malignancies: analysis of sixty patients.
Fain O; Hamidou M; Cacoub P; Godeau B; Wechsler B; Pariès J; Stirnemann J; Morin AS; Gatfosse M; Hanslik T; Belmatoug N; Blétry O; Cevallos R; Delevaux I; Fisher E; Hayem G; Kaplan G; Le Hello C; Mouthon L; Larroche C; Lemaire V; Piette AM; Piette JC; Ponge T; Puechal X; Rossert J; Sarrot-Reynauld F; Sicard D; Ziza JM; Kahn MF; Guillevin L
Arthritis Rheum; 2007 Dec; 57(8):1473-80. PubMed ID: 18050165
[TBL] [Abstract][Full Text] [Related]
50. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
51. Management and follow-up of localized Wegener's granulomatosis: a review of five cases.
Nishiike S; Kato T; Nagai M; Konishi M; Sakata Y
Acta Otolaryngol; 2004 Nov; 124(9):1103-8. PubMed ID: 15513558
[TBL] [Abstract][Full Text] [Related]
52. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
Haubitz M; Koch KM; Brunkhorst R
Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
[TBL] [Abstract][Full Text] [Related]
53. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort.
Matteson EL; Gold KN; Bloch DA; Hunder GG
Am J Med; 1996 Aug; 101(2):129-34. PubMed ID: 8757351
[TBL] [Abstract][Full Text] [Related]
54. Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.
Chanseaud Y; Tamby MC; Guilpain P; Reinbolt J; Kambouchner M; Boyer N; Noël LH; Guillevin L; Boissier MC; Mouthon L
J Autoimmun; 2005 Mar; 24(2):169-79. PubMed ID: 15829409
[TBL] [Abstract][Full Text] [Related]
55. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
56. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
57. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
Semple D; Keogh J; Forni L; Venn R
Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
[TBL] [Abstract][Full Text] [Related]
58. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
59. Splenic involvement in Wegener's granulomatosis.
Gal AA; Masor JJ
Arch Pathol Lab Med; 1996 Oct; 120(10):974-7. PubMed ID: 12046612
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients.
Charlier C; Henegar C; Launay O; Pagnoux C; Berezné A; Bienvenu B; Cohen P; Mouthon L; Guillevin L
Ann Rheum Dis; 2009 May; 68(5):658-63. PubMed ID: 18504289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
